206 related articles for article (PubMed ID: 10369817)
1. Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study.
Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Morris RG; Clough C; Brooks DJ; Turjanski N
J Neurol Neurosurg Psychiatry; 1999 Jul; 67(1):20-6. PubMed ID: 10369817
[TBL] [Abstract][Full Text] [Related]
2. Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.
Hu MT; Taylor-Robinson SD; Chaudhuri KR; Bell JD; Labbé C; Cunningham VJ; Koepp MJ; Hammers A; Morris RG; Turjanski N; Brooks DJ
Brain; 2000 Feb; 123 ( Pt 2)():340-52. PubMed ID: 10648441
[TBL] [Abstract][Full Text] [Related]
3. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
4. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.
Baik HM; Choe BY; Son BC; Jeun SS; Kim MC; Lee KS; Kim BS; Lee JM; Lee HK; Suh TS
Eur J Radiol; 2003 Sep; 47(3):179-87. PubMed ID: 12927660
[TBL] [Abstract][Full Text] [Related]
6. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
7. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.
Choe BY; Park JW; Lee KS; Son BC; Kim MC; Kim BS; Suh TS; Lee HK; Shinn KS
Invest Radiol; 1998 Aug; 33(8):450-5. PubMed ID: 9704284
[TBL] [Abstract][Full Text] [Related]
8. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.
Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM
Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163
[TBL] [Abstract][Full Text] [Related]
9. Primary motor area-related injury of anterior central gyrus in Parkinson's disease with dyskinesia: A study based on MRS and Q-space.
Yuan M; Du N; Song Z
Neurosci Lett; 2023 May; 805():137224. PubMed ID: 37019268
[TBL] [Abstract][Full Text] [Related]
10. Application of proton magnetic resonance spectroscopy on substantia nigra metabolites in Parkinson's disease.
Zhou B; Yuan F; He Z; Tan C
Brain Imaging Behav; 2014 Mar; 8(1):97-101. PubMed ID: 23955491
[TBL] [Abstract][Full Text] [Related]
11. Reduced brain glutamate in patients with Parkinson's disease.
Griffith HR; Okonkwo OC; O'Brien T; Hollander JA
NMR Biomed; 2008 May; 21(4):381-7. PubMed ID: 17907264
[TBL] [Abstract][Full Text] [Related]
12. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ
Metab Brain Dis; 1999 Mar; 14(1):45-55. PubMed ID: 10348313
[TBL] [Abstract][Full Text] [Related]
13. Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study.
Lucetti C; Del Dotto P; Gambaccini G; Ceravolo R; Logi C; Berti C; Rossi G; Bianchi MC; Tosetti M; Murri L; Bonuccelli U
Mov Disord; 2007 Nov; 22(15):2170-5. PubMed ID: 17722082
[TBL] [Abstract][Full Text] [Related]
14. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
Levin BE; Katzen HL; Maudsley A; Post J; Myerson C; Govind V; Nahab F; Scanlon B; Mittel A
J Neuroimaging; 2014; 24(1):39-44. PubMed ID: 23228009
[TBL] [Abstract][Full Text] [Related]
15. 1H-MRS experiences after bilateral DBS of the STN in Parkinson's disease.
Llumiguano C; Kovacs N; Usprung Z; Schwarcz A; Dóczi TP; Balas I
Parkinsonism Relat Disord; 2008; 14(3):229-32. PubMed ID: 17913561
[TBL] [Abstract][Full Text] [Related]
16. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
[TBL] [Abstract][Full Text] [Related]
17. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients.
Lucetti C; Del Dotto P; Gambaccini G; Bernardini S; Bianchi MC; Tosetti M; Bonuccelli U
Neurol Sci; 2001 Feb; 22(1):69-70. PubMed ID: 11487206
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Braak staging of brain pathology with
Cao H; Shi J; Cao B; Kang B; Zhang M; Qu Q
Neurosci Lett; 2017 Nov; 660():57-62. PubMed ID: 28844732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
